The rapid escalation of the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo since its May 2026 declaration has defined trader sentiment, with cases surging past 5,800 and deaths exceeding 2,700 by late August amid conflict-driven mobility and limited approved vaccines or treatments for this strain. Confirmed detections in Uganda (20 cases before the outbreak ended in July) and one imported case in France anchor near-certain resolutions for those markets, while modeling highlights elevated risks for neighbors like South Sudan due to porous borders and population movement. Ongoing WHO-declared PHEIC status, contact tracing gains, and frontline vaccination campaigns could curb further spread, but any undetected cross-border transmission before year-end remains the key swing factor for additional countries.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$34,949 Обс.
Dec 31, 2026
South Sudan
62%
Rwanda
28%
Burundi
28%
United States
25%
Canada
24%
Kenya
28%
India
14%
Republic of the Congo
21%
Nigeria
16%
Ethiopia
51%
Somalia
36%
China
13%
$34,949 Обс.
South Sudan
$2,181 Обс.
62%
Rwanda
$2,128 Обс.
28%
Burundi
$200 Обс.
28%
United States
$10,215 Обс.
25%
Canada
$1,418 Обс.
24%
Kenya
$235 Обс.
28%
India
$732 Обс.
14%
Republic of the Congo
$12,170 Обс.
21%
Nigeria
$25 Обс.
16%
Ethiopia
$107 Обс.
51%
Somalia
$71 Обс.
36%
China
$3,512 Обс.
13%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The rapid escalation of the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo since its May 2026 declaration has defined trader sentiment, with cases surging past 5,800 and deaths exceeding 2,700 by late August amid conflict-driven mobility and limited approved vaccines or treatments for this strain. Confirmed detections in Uganda (20 cases before the outbreak ended in July) and one imported case in France anchor near-certain resolutions for those markets, while modeling highlights elevated risks for neighbors like South Sudan due to porous borders and population movement. Ongoing WHO-declared PHEIC status, contact tracing gains, and frontline vaccination campaigns could curb further spread, but any undetected cross-border transmission before year-end remains the key swing factor for additional countries.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Ринок відкрито: May 22, 2026, 12:35 PM ET
Обсяг
$34,949Дата завершення
Jan 1, 2027Ринок відкрито
May 22, 2026, 12:35 PM ETВирішувач
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The rapid escalation of the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo since its May 2026 declaration has defined trader sentiment, with cases surging past 5,800 and deaths exceeding 2,700 by late August amid conflict-driven mobility and limited approved vaccines or treatments for this strain. Confirmed detections in Uganda (20 cases before the outbreak ended in July) and one imported case in France anchor near-certain resolutions for those markets, while modeling highlights elevated risks for neighbors like South Sudan due to porous borders and population movement. Ongoing WHO-declared PHEIC status, contact tracing gains, and frontline vaccination campaigns could curb further spread, but any undetected cross-border transmission before year-end remains the key swing factor for additional countries.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Обсяг
$34,949Дата завершення
Jan 1, 2027Ринок відкрито
May 22, 2026, 12:35 PM ETВирішувач
0x65070BE91...The rapid escalation of the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo since its May 2026 declaration has defined trader sentiment, with cases surging past 5,800 and deaths exceeding 2,700 by late August amid conflict-driven mobility and limited approved vaccines or treatments for this strain. Confirmed detections in Uganda (20 cases before the outbreak ended in July) and one imported case in France anchor near-certain resolutions for those markets, while modeling highlights elevated risks for neighbors like South Sudan due to porous borders and population movement. Ongoing WHO-declared PHEIC status, contact tracing gains, and frontline vaccination campaigns could curb further spread, but any undetected cross-border transmission before year-end remains the key swing factor for additional countries.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання